scorecardresearch
Add as a preferred source on Google
Saturday, September 27, 2025
HomeHealth

Health

Antibiotic Zaynich holds promise of becoming ‘game-changer’ in fight against antimicrobial resistance

Mumbai-based Wockhardt has completed phase 3 clinical trials in nearly 400 patients. Pharma firm looking to file for regulatory approvals in India, US and other countries in 2025.

Blood tests are currently one-size-fits-all. Normal ranges vary from person to person

Differences between a patient’s true normal range and the population-based reference interval can create problems for doctors. It interferes with the ability to diagnose a disease.

Govt says no plan to ban heartburn drug ranitidine, carcinogenic impurities within safe limits

In 2019, evidence showed that an impurity in drug degrades over time to form probable carcinogenic compound. Ranitidine is sold as heartburn medicine under names Rantac, Aciloc & Zinetac.

Swapping ghar ka khaana with ready-to-eat foods? 66% beverages have high sugar, 97% snacks high fat

Govt-funded study analysed front and back of labels of 432 popular packaged food products including breakfast cereals, idli mixes, porridges, soup mixes, beverages and extruded snacks.

Flu virus remains infectious in refrigerated raw milk: Study

California , December 14 (ANI): According to a new study, raw milk, which is marketed as a natural and healthful alternative to pasteurised dairy,...

3.42 lakh fraud cases detected under Ayushman Bharat-PMJAY. Over 56,000 unnecessary surgeries

Health Ministry tells Parliament that measures are in place to detect & prevent fraud. With 8.39 crore hospital admissions under the scheme, fraudulent cases are under 0.5%.

Cipla set to bring Afrezza, 1st inhalable insulin since Exubera, to Indian markets by 2025

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, received CDSCO approval this week.

In 1st real-term drop since 2000, global health spends fell in 2022 after Covid-era rise—WHO report

Global health spending stood at $9.8 trillion or 9.9% of world GDP in 2022, down from 2021 but above 2019 levels. Government spending on health per person dropped in all income groups.

India sees 69% drop in malaria cases from 2017 to 2023, exits WHO’s ‘high burden high incidence’ group

The country has set a target of eliminating the disease by 2030, in line with WHO’s Global Technical Strategy that aims to reduce malaria case incidence & deaths by at least 90% in 6 yrs.

Drop in number of Bangladeshi patients may hurt Indian hospitals. Strained ties, visa curbs to blame

Bangladesh nationals have usually formed a major chunk of India’s total medical tourist footfall. Now, they may be turning to Thailand, Malaysia, Turkey & even Pakistan.

On Camera

Aamir Khan and Salman Khan are still dodging and deflecting the age question, 20 yrs later

On the first episode of Two Much With Kajol and Twinkle, Aamir Khan and Salman Khan were confronted with another hypocrisy: age gaps. And they didn't come out looking good.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

With MiG-21’s exit, India’s squadron strength hits 6-decade low. What are IAF’s plans for the Tejas

While the IAF remains committed to the Tejas programme and has placed orders for 180 Tejas Mk1A, the force is eagerly waiting for the Tejas Mk 2 version.

Something’s hidden in the Oval Office photo of Trump, Munir, Sharif. India must look closely

What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.